Terry-Ann Burrell, Chief Financial Officer at Beam Therapeutics Inc. (BEAM), sold 73,406 shares at $45.08 ($3.3M) on 2023-01-27, disclosed to the SEC on 2023-01-30.
Open-market sale of $3.3M BEAM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.16 | 1,102 | $50K | 1.5% |
| 2 | $45.08 | 36,152 | $1.6M | 49.2% |
| 3 | $45.08 | 36,152 | $1.6M | 49.2% |
| Total | $45.08 avg | 73,406 | $3.3M | 100% |
| Filing → |
| BEAM | SELL | 2023-04-05 | $276K | — | Filing → |
| BEAM | SELL | 2023-01-25 | $1.8M | — | Filing → |
| BEAM | SELL | 2023-01-20 | $4.3M | — | Filing → |